Cyclosporine for Behcet's uveitis: is it associated with an increased risk of neurological involvement?

dc.contributor.author	Mutlu, M.
dc.contributor.author	Tugal-Tutkun, I.
dc.contributor.author	Vanli, E. N.
dc.contributor.author	Akman-Demir, G.
dc.contributor.author	Kurtuncu, M.
dc.contributor.author	Ayranci, O.
dc.date.accessioned	2021-03-04T07:53:46Z
dc.date.available	2021-03-04T07:53:46Z
dc.date.issued	2008
dc.identifier.citation	Akman-Demir G., Ayranci O., Kurtuncu M., Vanli E. N. , Mutlu M., Tugal-Tutkun I., "Cyclosporine for Behcet's uveitis: is it associated with an increased risk of neurological involvement?", CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, cilt.26, sa.4, 2008
dc.identifier.issn	0392-856X
dc.identifier.other	vv_1032021
dc.identifier.other	av_60763cef-c3d8-4238-bb10-6219eee751ea
dc.identifier.uri	http://hdl.handle.net/20.500.12627/67303
dc.description.abstract	Objective. The immunosuppressant cyclosporine is widely used to treat Behcets disease (BD). The aim of this study was to determine whether cyclosporine increases the risk of neurological involvement in BD.
dc.language.iso	eng
dc.subject	Dahili Tıp Bilimleri
dc.subject	İmmünoloji ve Romatoloji
dc.subject	Sağlık Bilimleri
dc.subject	Tıp
dc.subject	Klinik Tıp (MED)
dc.subject	Klinik Tıp
dc.subject	ROMATOLOJİ
dc.subject	İç Hastalıkları
dc.title	Cyclosporine for Behcet's uveitis: is it associated with an increased risk of neurological involvement?
dc.type	Makale
dc.relation.journal	CLINICAL AND EXPERIMENTAL RHEUMATOLOGY
dc.contributor.department	İstanbul Üniversitesi , ,
dc.identifier.volume	26
dc.identifier.issue	4
dc.contributor.firstauthorID	188567

Bu öğenin dosyaları:

Dosyalar	Boyut	Biçim	Göster
Bu öğe ile ilişkili dosya yok.